Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Industry Floats Idea Of User Fees For Reviewer Training

This article was originally published in The Gray Sheet

Executive Summary

The device industry may be willing to contribute user fee funds to improve FDA reviewer training and retention, according to industry insider Paul LaViolette.

You may also be interested in...



FDA Puts 510(k) Review Training Enhancements On Hold, Awaits Final Reports

FDA says it has put planned enhancements to 510(k) reviewer training on hold until it sees the final results of its internal 510(k) program assessment and the Institute of Medicine's upcoming report on the pre-market clearance program.

FDA Puts 510(k) Review Training Enhancements On Hold, Awaits Final Reports

FDA says it has put planned enhancements to 510(k) reviewer training on hold until it sees the final results of its internal 510(k) program assessment and the Institute of Medicine's upcoming report on the pre-market clearance program.

FDA User Fee Renewal Should Include Pre-Market Improvements - Industry

Consumer advocates are suggesting FDA request considerably more funding from device companies in the next round of user fee negotiations, but companies are reluctant to foot more of the bill for device reviews without seeing promised improvements in FDA's pre-market program

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT029503

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel